Transcatheter Aortic Valve Implantation: Recommendations for Practice Based on a Multidisciplinary Review Including Cost-Effectiveness and Ethical and Organizational Issues

Canadian Journal of Cardiology

Volumn 29, Issue 6, 2013, Pages 718-726

  Boothroyd, Lucy J ^a   Spaziano, Marco ^a   Guertin, Jason R ^a   Lambert, Laurie J ^a   Rodés Cabau, Josep ^b   Noiseux, Nicolas ^c   Nguyen, Michel ^d   Dumont, Éric ^b   Carrier, Michel ^e   de Varennes, Benoit ^f   Ibrahim, Reda ^e   Martucci, Giuseppe ^f   Xiao, Yongling ^a   Morin, Jean E ^a,f   Bogaty, Peter ^a,b  

^a Institut National d'Excellence en Sante et en Services Sociaux INESSS   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HEALTH CARE ORGANIZATION; HIGH RISK PATIENT; HUMAN; MEDICAL ETHICS; META ANALYSIS; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84878141303     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.09.002     Document Type: Review

References (52)

1. Iung B., Cachier A., Baron G., et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 2005, 26:2714-2720.
2. Gilard M., Eltchaninoff H., Iung B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012, 366:1705-1715.
3. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
4. Rajani R., Buxton W., Haworth P., et al. Prognostic benefit of transcatheter aortic valve implantation compared with medical therapy in patients with inoperable aortic stenosis. Catheter Cardiovasc Interv 2010, 75:1121-1126.
5. Sinning J.M., Ghanem A., Steinhauser H., et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010, 3:1141-1149.
6. Bosmans J.M., Kefer J., De Bruyne B., et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011, 12:762-767.
7. Tamburino C., Capodanno D., Ramondo A., et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011, 123:299-308.
8. Kapadia S.R., Goel S.S., Svensson L., et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009, 137:1430-1435.
9. Lefevre T., Kappetein A.P., Wolner E., et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011, 32:148-157.
10. Otten A.M., van Domburg R.T., van Gameren M., et al. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 2008, 4:250-255.
11. Rodés-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
12. Himbert D., Descoutures F., Al-Attar N., et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009, 54:303-311.
13. Thomas M., Schymik G., Walther T., et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011, 124:425-433.
14. Zierer A., Wimmer-Greinecker G., Martens S., Moritz A., Doss M. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement?. J Thorac Cardiovasc Surg 2009, 138:1067-1072.
15. Walther T., Kasimir M.T., Doss M., et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011, 39:532-537.
16. Grube E., Buellesfeld L., Mueller R., et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008, 1:167-175.
17. Gurvitch R., Wood D.A., Tay E.L., et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010, 122:1319-1327.
18. Thielmann M., Wendt D., Eggebrecht H., et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thoracic Surg 2009, 88:1468-1474.
19. Moat N.E., Ludman P., de Belder M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. J Am Coll Cardiol 2011, 58:2130-2138.
20. Makkar R.R., Fontana G.P., Jilaihawi H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. New Engl J Med 2012, 366:1696-1704.
21. Ussia G.P., Barbanti M., Petronio A.S., et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012, 33:969-976.
22. Svensson L.G., Dewey T., Kapadia S., et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008, 86:46-55.
23. Ussia G.P., Mule M., Barbanti M., et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009, 30:1790-1796.
24. Reynolds M.R., Magnuson E.A., Lei Y., et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011, 124:1964-1972.
25. Bekeredjian R., Krumsdorf U., Chorianopoulos E., et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol 2010, 106:1777-1781.
26. Wyrwich K.W., Spertus J.A., Kroenke K., Tierney W.N., Babu A.N., Wolinsky F.D. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J 2004, 147:615-622.
27. National Institute for Health and Clinical Excellence (NICE) Interventional procedure overview of transcatheter aortic valve implantation for aortic stenosis 2011, NICE, London, England, Available at:, Accessed September 16, 2012. http://www.nice.org.uk/nicemedia/live/11914/54190/54190.pdf.
28. Yan T.D., Cao C., Martens-Nielsen J., et al. Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: a systematic review. J Thorac Cardiovasc Surg 2010, 139:1519-1528.
29. Coeytaux R.R., Williams J.W., Gray R.N., Wang A. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann Intern Med 2010, 153:314-324.
30. Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines. Health Technology Inquiry Service (HTIS) 2010, CADTH, Ottawa, ON, Available at:, Accessed October 25, 2012. http://cadth.ca/media/pdf/l0149_percutaneous_heart_valves_htis-2.pdf.
31. McGregor M., Esfandiari S., Mines L. Transcatheter aortic valve implantation (TAVI) at the MUHC: a health technology assessment 2009, McGill University Health Centre (MUHC), Montreal, QC, Available at:, Accessed September 16, 2012. http://www.mcgill.ca/files/tau/TAVI_REPORT.pdf.
32. Leon M.B., Piazza N., Nikolsky E., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011, 57:253-269.
33. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Engl J Med 2011, 364:2187-2198.
34. Kodali S.K., Williams M.R., Smith C.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. New Engl J Med 2012, 366:1686-1695.
35. Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schunemann H.J. What is " quality of evidence" and why is it important to clinicians?. BMJ 2008, 336:995-998.
36. Sehatzadeh S., Doble B., Xie F., et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis. Ontario Health Technology Assessment Series 2012, 12:1-91.
37. Neyt M., Van Brabandt H., Van de Sande S., Devriese S. L'implantation percutanée de valves aortiques (TAVI): évaluation actualisée de la technologie. KCE reports 163B 2011, Centre fédéral d'expertise des soins de santé (KCE), Brussels, Belgium, Available at:, Accessed September 16, 2012. http://kce.fgov.be/sites/default/files/page_documents/kce_163b_tavi_actualisation.pdf.
38. Reynolds M.R., Magnuson E.A., Wang K., et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (Cohort B). Circulation 2012, 125:1102-1109.
39. Gold M.R., Siegel J.E., Russell L., et al. Cost-Effectiveness in Health and Medicine 1996, Oxford University Press, New York.
40. Rosengart T.K., Feldman T., Borger M.A., et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008, 117:1750-1767.
41. Vahanian A., Alfieri O., Al-Attar N., et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008, 29:1463-1470.
42. Haute Autorité de Santé (HAS) évaluation des bioprothèses valvulaires aortiques implantées par voie rétrograde transfémorale et transapicale 2008, HAS, Saint-Denis La Plaine, France, Available at:, Accessed September 16, 2012. http://www.has-sante.fr/portail/jcms/c_658884/evaluation-des-bioprotheses-valvulaires-aortiques-implantees-par-voie-retrograde-transfemorale-et-transapicale.
43. Holmes D.R., Mack M.J. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 58:445-455.
44. Webb J., Rodés-Cabau J., Fremes S., et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol 2012, 28:520-528.
45. Holmes D.R., Mack M.J., Kaul S., et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012, 59:1200-1254.
46. Ranucci M., Guarracino F., Castelvecchio S., Baldassarri R., Covello R.D., Landoni G. Surgical and transcatheter aortic valve procedures: the limits of risk scores. Interact Cardiovasc Thorac Surg 2010, 11:138-141.
47. Dewey T.M., Brown D., Ryan W.H., Herbert M.A., Prince S.L., Mack M.J. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008, 135:180-187.
48. Schenk S., Fritzsche D., Atoui R., Koertke H., Koerfer R., Eitz T. EuroSCORE-predicted mortality and surgical judgment for interventional aortic valve replacement. J Heart Valve Dis 2010, 19:5-15.
49. Van Brabandt H., Neyt M. Percutaneous heart valve implantation in congenital and degenerative valve disease: a rapid Health Technology Assessment. KCE reports 95C 2008, Centre fédéral d'expertise des soins de santé (KCE), Brussels, Belgium, Available at:, Accessed September 16, 2012. http://kce.fgov.be/sites/default/files/page_documents/d20081027381.pdf.
50. Haute Autorité de Santé (HAS) Réévaluation des bioprothèses valvulaires aortiques implantées par voie artérielle transcutanée ou par voie transapicale. Rapport d'évaluation 2011, HAS, Saint-Denis La Plaine, France, Available at:, Accessed October 25, 2012. http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/rapport_has_valves_aortiques_transcutanees_2011_h2com.pdf.
51. Tommaso C.L., Bolman R.M.I., Feldman T., et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator & institutional requirements for transcatheter valve repair and replacement; Part 1 TAVR. J Am Coll Cardiol 2012, 59:2028-2042.
52. Centers for Medicare and Medicaid Services (CMS) Proposed decision memo for transcatheter aortic valve replacement (TAVR) (CAG-00430N) 2012, CMS, U.S. Department of Health and Human Services, Baltimore, MD, Available at:, Accessed May 7, 2012. http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=257%26ver=5%26NcaName=Transcatheter+Aortic+Valve+Replacement+(TAVR)%26bc=AAAAAAAAIAAA%26.